When was Veran Medical founded?

Veran Medical was founded in 2005 and raised its 1st funding round within a year of its incorporation.

Where is Veran Medical located?

Veran Medical is headquartered in St. Louis, United States. It is registered at Overland, Missouri.

How many employees does Veran Medical have?

As of Mar 01, 2026, the latest employee count at Veran Medical is 10 - 49.

Is Veran Medical a funded company?

Veran Medical is a funded company, having raised a total of $155M across 15 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2005.

When was the latest funding round of Veran Medical?

Veran Medical's latest funding was a $***** Conventional Debt round on Dec 19, 2018, with participation from 1 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $3.79B in funding in 2026 to date.

Where does Veran Medical rank among its competitors?

Veran Medical ranks 4th amongst 10 active competitors, of which 7 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Selio Medical, which secured $5.81M in Aug, 2026.

Who are the top competitors of Veran Medical?

Veran Medical's top competitors include Body Vision Medical, LEADOPTIK and Selio Medical. Among them, Selio Medical secured the most recent funding round in August, 2026.

Veran Medical - 2026 Company Profile, Funding & Competitors

Q: Is Veran Medical an acquired company?

Veran Medical got acquired by Olympus on Dec 04, 2020.

Veran Medical is an acquired company based in St. Louis (United States), founded in 2005. It operates as a Provider of diagnosis of lung cancer by soft tissue navigation. Veran Medical has raised $155M in funding from investors like Prolog Ventures, Versant Ventures and RC Capital. The company has 10 active competitors, including 7 funded and 2 that have exited. Its top competitors include companies like Body Vision Medical, LEADOPTIK and Selio Medical.

Company Details

Veran Medical Technologies develops medical devices for detection and minimally invasive treatment of lung cancer. Veran's IG4 Plug-N-Play Delivery System uses electromagnetic navigation and respiratory tracking to enable physicians to target small lesions. Its IG4 Platform allows clinicians to visualize information integrated with a CT dataset, such as respiration, contrast-enhanced structures, PET, and ultrasound.

Website: veranmedical.com
Social
Registered Address: Overland, Missouri

Key Metrics

Founded Year

2005

Location

St. Louis, United States

Stage

Acquired

Total Funding

$155M in 15 rounds

Latest Funding Round

Conventional Debt, Dec 19, 2018, $*****

Investors

Prolog Ventures & 14 more

Ranked

4^th among 10 active competitors

Employee Count

10 - 49 as on Mar 01, 2026

Similar Companies

Body Vision Medical & 10 more

Exit Details

Acquired by Olympus (Dec 04, 2020)

View Veran Medical's full profile

Veran Medical is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
VERAN MEDICAL TECHNOLOGIES INC CIN: 270066043 , United States, Active	Dec 26, 999	-	126 (As on Dec 31, 2020)	-

Veran Medical got acquired by Olympus on Dec 04, 2020 at an acquisition amount of $*****.

Click here to take a look at Veran Medical's acquisition in detail

Veran Medical has raised a total funding of $155M over 15 rounds. Its first funding round was on 2005. Its latest funding round was a Conventional Debt round on Dec 19, 2018 for $*****. 1 investor participated in its latest round. Veran Medical has 15 institutional investors.

Here is the list of recent funding rounds of Veran Medical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 19, 2018	6920889	Conventional Debt	5287215	2397261	2422435	2117180
Nov 14, 2018	4827329	Series D	2019534	1392917	7877951	5325186
Dec 21, 2016	4004728	Series D	4416076	1317519	Versant Ventures & 1 more	Oxford Finance

Access funding benchmarks and valuations. Sign up today!

View details of Veran Medical's funding rounds and investors

Veran Medical's employee count trend

Veran Medical has 10 - 49 employees as of Mar 26. Here is Veran Medical's employee count trend over the years:

Uncover Veran Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Veran Medical include Body Vision Medical, LEADOPTIK and Selio Medical. Here is the list of Top 10 competitors of Veran Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Body Vision Medical 2014, Waltham (United States), Series C	Developer of AI-driven imaging system for lung cancer diagnostic intervention	$28.5M	Business Asia Consulting, SPRIM Global Investments ... & 8 others	61/100
2nd	LEADOPTIK 2020, Milpitas (United States), Seed	Provider of AI-powered optical processors	$11.2M	HAX, MetaVC Partners & 7 others	58/100
3rd	Selio Medical 2016, Dublin (Ireland), Series A	Developer of device to prevent pneumothorax during transthoracic needle biopsy	$5.81M	EIC Fund, MedTech Innovator & 2 others	51/100
4th	Veran Medical 2005, St. Louis (United States), Acquired	Provider of diagnosis of lung cancer by soft tissue navigation	$155M	Versant Ventures, Vensana Capital & 13 others	46/100
5th	Prana Thoracic 2022, Houston (United States), Series A	Developer of minimally invasive lung tissue excision tool for lung cancer	$7.5M	New World Angels, cultivate(MD) & 7 others	39/100
6th	Prothea Technologies 2024, Edinburgh (United Kingdom), Series A	Provider of lung cancer biopsy and treatments	$12.7M	Earlybird, Merieux Equity Partners & 2 others	38/100
7th	Spiromagic 2014, Gribskov (Denmark), Seed	Provider of a smartphone connected spirometer to measure lung function	$704K	Ministry of Education and Research, Syddansk Innovation ... & 2 others	31/100
8th	Suzhou Lung Care Medical Technologies 2015, Suzhou (China), Series B	A Bronchoscope placement navigation system	-	Shenghui Yongchen, Infinity Group & 2 others	30/100
9th	Cirrus Bio 2021, Phoenix (United States), Acquired	Developer of multi omic solutions for the diagnosis and management of diseases	-	-	23/100
10th	Guide-X 2007, Qiryat Shemona (Israel), Deadpooled	Developing an apparatus for accurate needles insertion for diagnosing cancerous diseases	-	-	21/100